Mato S - Search Results

1

Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.

Lafourcade M, Elezgarai I, Mato S, Bakiri Y, Grandes P, Manzoni OJ. Lafourcade M, et al. Among authors: mato s. PLoS One. 2007 Aug 8;2(8):e709. doi: 10.1371/journal.pone.0000709. PLoS One. 2007. PMID: 17684555 Free PMC article.

2

A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens.

Fourgeaud L, Mato S, Bouchet D, Hémar A, Worley PF, Manzoni OJ. Fourgeaud L, et al. Among authors: mato s. J Neurosci. 2004 Aug 4;24(31):6939-45. doi: 10.1523/JNEUROSCI.0671-04.2004. J Neurosci. 2004. PMID: 15295029 Free PMC article.

3

Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta 9-tetrahydrocannabinol exposure.

Mato S, Robbe D, Puente N, Grandes P, Manzoni OJ. Mato S, et al. J Neurosci. 2005 Dec 14;25(50):11619-27. doi: 10.1523/JNEUROSCI.2294-05.2005. J Neurosci. 2005. PMID: 16354920 Free PMC article.

4

Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens.

Mato S, Lafourcade M, Robbe D, Bakiri Y, Manzoni OJ. Mato S, et al. Neuropharmacology. 2008 Jan;54(1):87-94. doi: 10.1016/j.neuropharm.2007.04.014. Epub 2007 May 5. Neuropharmacology. 2008. PMID: 17606273

5

Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions.

Lafourcade M, Larrieu T, Mato S, Duffaud A, Sepers M, Matias I, De Smedt-Peyrusse V, Labrousse VF, Bretillon L, Matute C, Rodríguez-Puertas R, Layé S, Manzoni OJ. Lafourcade M, et al. Among authors: mato s. Nat Neurosci. 2011 Mar;14(3):345-50. doi: 10.1038/nn.2736. Epub 2011 Jan 30. Nat Neurosci. 2011. PMID: 21278728

6

A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity.

Mato S, Chevaleyre V, Robbe D, Pazos A, Castillo PE, Manzoni OJ. Mato S, et al. Nat Neurosci. 2004 Jun;7(6):585-6. doi: 10.1038/nn1251. Epub 2004 May 16. Nat Neurosci. 2004. PMID: 15146190

7

Targeting the endocannabinoid system in the treatment of fragile X syndrome.

Busquets-Garcia A, Gomis-González M, Guegan T, Agustín-Pavón C, Pastor A, Mato S, Pérez-Samartín A, Matute C, de la Torre R, Dierssen M, Maldonado R, Ozaita A. Busquets-Garcia A, et al. Among authors: mato s. Nat Med. 2013 May;19(5):603-7. doi: 10.1038/nm.3127. Epub 2013 Mar 31. Nat Med. 2013. PMID: 23542787

8

Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.

Manterola A, Bernal-Chico A, Cipriani R, Canedo-Antelo M, Moreno-García Á, Martín-Fontecha M, Pérez-Cerdá F, Sánchez-Gómez MV, Ortega-Gutiérrez S, Brown JM, Hsu KL, Cravatt B, Matute C, Mato S. Manterola A, et al. Among authors: mato s. Biochem Pharmacol. 2018 Nov;157:189-201. doi: 10.1016/j.bcp.2018.07.042. Epub 2018 Aug 1. Biochem Pharmacol. 2018. PMID: 30075103 Free PMC article.

9

Spatial organization of neuron-astrocyte interactions in the somatosensory cortex.

Baraibar AM, Belisle L, Marsicano G, Matute C, Mato S, Araque A, Kofuji P. Baraibar AM, et al. Among authors: mato s. Cereb Cortex. 2023 Apr 4;33(8):4498-4511. doi: 10.1093/cercor/bhac357. Cereb Cortex. 2023. PMID: 36124663 Free PMC article.

10

Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain.

Mato S, Del Olmo E, Pazos A. Mato S, et al. Eur J Neurosci. 2003 May;17(9):1747-54. doi: 10.1046/j.1460-9568.2003.02599.x. Eur J Neurosci. 2003. PMID: 12752773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page